Clinics of Oncology
About Us
Author Guidelines
Contact
Editor in Chief
Editorial Board
Home
Peer Review Process
Submit Manuscript
Terms & Conditions
Volumes
Both XELIRI And TEGAFIRI Together with Bevacizumab are Effective forRecurrent or Metastatic Colorectal Cancer: A Real-Life Experience
Apr 5, 2024
—
by
kiransyapu@gmail.com
in
Volume 3
Research Article
←
Previous:
Appearance of Krukenberg Tumor from Gastric Carcinoma, Usand Ct Evaluation
Next:
A Combination of Taxol and SC-560 Regulates Ki-67 Expressionand Apoptosis in Human Ovarian Carcinoma Xenografts
→
error:
Content is protected !!